RELIGAREReligare Enterprises Limited
Insurance · Insurance - Life · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Religare Enterprises Limited, through its subsidiaries, provides various financial services in India and internationally. It operates through Investment and Financing Activities; Broking Related Activities; E-Governance; and Insurance segments. The company provides small and medium enterprise financing; and housing finance products comprising home-purchase, home construction, and home improvement loans. It also offers broking services in equity, currency, and commodity; and depository participant services, as well as operates as a NSDL-appointed enrolment agency for Aadhaar Unique Identification Number, and a mutual fund distributor. In addition, the company provides health, critical illness, personal accident, top-up coverage, international travel, and maternity insurance products, as well as group health and personal accident insurance for corporates. Further, the company engages in the permanent account number issuance; tax deduction and collection account number and e-TDS returns; acting as a business correspondent for banking services; bharat bill payment systems and recharges; ticketing for airlines, railways, buses, and tourism through online and offline platforms; digital signature certificate and token services; and operating as a central record keeping agency facilitation center. The company was incorporated in 1984 and is headquartered in New Delhi, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on RELIGARE — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 29/100)
- • Profit growth: -31.0% YoY
- • ROE: 3.0%
- • RSI: 29
- • MACD: bearish
Bull case
- • Revenue growth: 26.0% YoY
- • Debt/Equity: 0.13
- • Promoter holding: 49.8%
- • Trend strength (ADX): 36
Bear case
- • Profit growth: -31.0% YoY
- • ROE: 3.0%
- • RSI: 29
- • MACD: bearish
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Momentum is fading versus the broader market
- • Profit growth: -31.0% YoY
- • ROE: 3.0%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹6.82). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.